ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial | Dr Koo

Подробнее о видео

Watch the full video on Radcliffe Cardiology here:

In this short interview from our coverage of ACC 22 late-breaking trials, Dr Bon Kwon Koo (Seoul National University Hospital, Seoul, KR) discusses the FLAVOUR trial. FLAVOUR was a multicentre, non-inferiority, randomised clinical trial which sought to compare the safety and efficacy of FFR-guided stenting and IVUS-guided stenting.

Discussion Points:

-Background to the study
-Study design
-Key findings
-Impact on clinical practice
-Next steps
-Take-home messages

Recorded remotely from ACC, Washington DC, 2022.
Interviewer: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.